Sort by
Refine Your Search
-
, and teaching. In partnership with Northeastern University, Takeda Pharmaceuticals is offering a two-year Clinical Sciences PharmD/PhD fellowship based in Cambridge, MA. Takeda Pharmaceutical Company
-
, and teaching. In partnership with Northeastern University, Takeda Pharmaceuticals U.S.A, Inc. is offering a two-year Clinical Sciences PharmD/PhD fellowship based in Cambridge, MA. Takeda Pharmaceutical
-
About the Opportunity Khoury College of Computer Sciences is looking for a Distinguished Research Fellow. Responsibilities: The Distinguished Research Fellow will be expected to start-up their own
-
offers opportunities, an environment, and a culture that just aren’t found together anywhere else. This is the right place for you if you’re curious, motivated by the future of technology, and want to be
-
, an environment, and a culture that just aren’t found together anywhere else. This is the right place for you if you’re curious, motivated by the future of technology, and want to be part of a unique and diverse
-
About the Opportunity The College of Social Sciences and Humanities (CSSH) combines Northeastern University’s signature approach to experiential learning with liberal arts education
-
. Mechanobiology in aging in the musculoskeletal system or the cardiovascular system: this area focuses on the application of mechanobiology technology and discovery to the aging research. 2. Immunomechanobiology
-
Disorder is a collaboration between CDD training faculty based in the Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology at Northeastern University in Boston, MA (Drs. Raymond Booth
-
diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause
-
of specific proteins in a cancer cell’s nucleus with SINE technology. Our primary focus is on developing novel drugs which we hope will help treat patients with certain blood cancers or solid tumor malignancies